Related Experiment Video
Updated: Jul 15, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Prognostic Value of Mitral Annular Calcification in Liver Transplant Patients: Implication in Posttransplant Outcomes
Hwa-Young Jang1, Sang-Bin Han, Jun-Hyeop Jeong
1Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Insights
Mitral annular calcification (MAC) in liver transplant (LT) candidates is linked to higher short-term cardiac events and worse long-term survival, particularly in women. Early identification and management of MAC are vital for improving LT outcomes.
Area of Science:
- Cardiology
- Hepatology
- Transplantation Medicine
Background:
- Metabolic diseases and aging increase the prevalence of mitral annular calcification (MAC) in liver transplant (LT) candidates.
- Cardiovascular disease is a leading cause of mortality in LT recipients, yet the impact of MAC remains understudied.
- This study examines MAC prevalence, associated factors, and its effect on LT outcomes.
Purpose of the Study:
- To investigate the prevalence of mitral annular calcification (MAC) in liver transplant (LT) candidates.
- To identify factors associated with MAC in this population.
- To determine the impact of pre-LT MAC on major adverse cardiac events (MACE) and long-term survival after LT.
Main Methods:
- A cohort of 4148 LT patients undergoing pretransplant echocardiography from 2008-2019 was analyzed.
- Multivariate logistic analysis and Shapley additive explanation (SHAP) scores were used to identify significant factors related to MAC.
- Primary outcome was 30-day MACE; secondary outcome was 5-year cumulative all-cause mortality.
Main Results:
- MAC was present in 3.0% of patients, associated with age, alcoholic liver disease, chronic kidney disease, hyperuricemia, hypertension, and coronary artery disease.
- Patients with MAC had significantly higher 30-day MACE rates (adjusted HR 1.67) and poorer cumulative survival (adjusted HR 1.47).
- Women with MAC showed a markedly poorer long-term survival probability compared to men without MAC (>10 years post-LT).
Conclusions:
- Pre-LT MAC is associated with increased short-term MACE and reduced long-term survival.
- Women with MAC represent a particularly high-risk group for adverse outcomes post-LT.
- Identifying and managing MAC and its risk factors are critical for enhancing post-LT patient survival.
Background:
With the rise of metabolic diseases and aging in liver transplant (LT) candidates, mitral annular calcification (MAC) is more recognizable. Despite cardiovascular risk becoming a leading cause of mortality in LT recipients, the influence of MAC remains unexamined. This study investigates the prevalence, related factors, and impact of MAC on LT outcomes.
Methods:
We explored 4148 consecutive LT patients who underwent routine pretransplant echocardiography from 2008 to 2019. Multivariate logistic analysis and the tree-based Shapley additive explanation scores in machine learning were used to evaluate the significant and important related factors. The primary outcome was 30-d major adverse cardiac events (MACE), and the secondary outcome was a median of 5-y cumulative all-cause mortality.
Results:
MAC was found in 123 (3.0%) patients. Significant and important related factors included age, alcoholic liver disease, chronic kidney disease, hyperuricemia, hypertension, and coronary artery disease. The MACE rate was higher in patients with MAC compared with those without MAC at 30 d ( P < 0.001, adjusted hazard ratio 1.67; 95% confidence interval, 1.08-2.57). Patients with MAC had poorer cumulative overall survival probability compared with those without MAC ( P = 0.0016; adjusted hazard ratio 1.47; 95% confidence interval, 1.01-2.15). Specifically, women with MAC had a poorer survival probability compared with men without MAC (65.0% versus 80.7%, P < 0.001) >10 y post-LT.
Conclusions:
The presence of MAC before LT was linked to increased 30-d MACE and lower long-term survival rates, especially in women. Identification and management of MAC and potential risk factors are crucial for improving post-LT survival.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests

